<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Two subpopulations were isolated on the basis of soybean agglutinin (SBA) binding, from the human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line Daudi </plain></SENT>
<SENT sid="1" pm="."><plain>The low- and high-binder sublines maintained this characteristic in continuous passages </plain></SENT>
<SENT sid="2" pm="."><plain>Their surface marker profiles, antibodies, scanning electron microscope (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>), cytochemical reactions and binding of other lectins (concanavalin A and wheatgerm agglutinin) were not different </plain></SENT>
<SENT sid="3" pm="."><plain>They differed, however, in growth potential in athymic mice </plain></SENT>
<SENT sid="4" pm="."><plain>The low-binder subline had lower frequency of takes, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> weight and volume, and did not <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasize</z:e> as compared to the high-binder subline </plain></SENT>
<SENT sid="5" pm="."><plain>However, the reaction with F-SBA of <z:hpo ids='HP_0000001'>all</z:hpo> the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells examined was strong (greater than 70%), indicating in vivo selection and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development of high binder cells </plain></SENT>
</text></document>